* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Mito-AUTAC technology is a mitochondria-oriented Autophagy-Targeting Chimera (AUTAC) strategy designed to induce selective mitochondrial clearance through the autophagy-lysosome pathway. A typical Mito-AUTAC molecule contains three functional elements: a mitochondria-targeting warhead that directs the molecule to mitochondrial membranes or mitochondrial-associated proteins, an autophagy-recruiting degradation tag that promotes autophagy-recognition signals such as K63-linked ubiquitination, and a linker that controls distance, flexibility, polarity, and spatial orientation between the two functional modules. The effectiveness of a Mito-AUTAC design depends on mitochondrial localization, tag exposure, linker geometry, cell model compatibility, and the ability to distinguish true mitophagy from nonspecific mitochondrial stress.
BOC Sciences provides integrated Mito-AUTAC technology development services for pharmaceutical, biotechnology, academic, and CRO research teams seeking to explore mitochondrial degradation beyond conventional small-molecule modulation. Our support covers mitochondrial target feasibility assessment, warhead and degradation tag design, linker engineering, Mito-AUTAC synthesis, mitophagy assay development, K63-linked ubiquitination analysis, mitochondrial function profiling, phenotypic model validation, and iterative optimization. By connecting chemistry, mitochondrial biology, and mechanism-focused evaluation, we help clients build Mito-AUTAC programs with clearer design logic and more actionable research data.
Services
BOC Sciences' Comprehensive Mito-AUTAC Technology Development Services
Mitochondrial Target Assessment and Feasibility Analysis
The first step in Mito-AUTAC development is to determine whether the selected mitochondrial target, damaged organelle population, or disease-relevant mitochondrial phenotype is suitable for selective autophagy-mediated clearance. BOC Sciences evaluates target accessibility, mitochondrial localization, pathway context, cellular readout feasibility, and early biological risks to help clients define a technically sound development strategy.
Mitochondrial dysfunction target screening: evaluation of disease-associated mitochondrial proteins, damaged mitochondrial fragments, organelle accessibility, biological relevance, and autophagic clearance potential
Mitophagy pathway compatibility analysis: assessment of baseline autophagy level, mitochondrial fragmentation characteristics, and Parkin-dependent or Parkin-independent pathway activity in selected cell models
Early risk mapping: evaluation of energy crisis risk caused by excessive mitochondrial clearance, off-target mitochondrial toxicity, and feasibility of mitochondrial readout design
Mitochondria-Targeting Warhead Design
Mito-AUTAC molecules require a mitochondrial-targeting warhead that can direct the degrader to the intended mitochondrial membrane compartment or mitochondrial protein environment. We support the design, screening, derivatization, and validation of mitochondrial ligands while ensuring that AUTAC conjugation does not compromise organelle targeting, membrane penetration, or target-binding activity.
Mitochondrial membrane-targeting ligand screening: design or screening of small-molecule ligands targeting the translocase of the outer mitochondrial membrane/translocase of the inner mitochondrial membrane (TOM/TIM) complexes, inner mitochondrial membrane, or matrix-associated proteins
Derivatization of known mitochondrial ligands: AUTAC-compatible modification of triphenylphosphonium (TPP+), indole derivatives such as 2-phenylindole used in AUTAC4-inspired designs, and other mitochondria-associated scaffolds
Ligand–mitochondria binding validation: confirmation of mitochondrial targeting specificity through co-localization imaging, mitochondrial fractionation, and subcellular distribution analysis
Autophagy-Recruiting Degradation Tag and Linker Engineering
The autophagy-recruiting degradation tag and linker architecture determine whether a Mito-AUTAC molecule can efficiently generate autophagy-recognition signals and support mitophagy-associated clearance. BOC Sciences optimizes tag structure, linker length, linker flexibility, conjugation site, molecular polarity, and cLogP to balance mitochondrial membrane penetration, K63-linked ubiquitination induction, and autophagosome recruitment efficiency.
Autophagy-recruiting degradation tag optimization: selection and modification of 8-nitro-cyclic guanosine monophosphate (8-nitro-cGMP)-inspired degradation tags or related functional motifs to improve K63-linked ubiquitination induction and autophagy pathway engagement
Linker length and flexibility design: linker engineering adapted to the double-membrane structure of mitochondria to balance membrane penetration and autophagosome recruitment
Linker attachment site analysis: identification of optimal conjugation sites between the mitochondrial-targeting warhead and tag-displaying domain to reduce steric hindrance
Molecular polarity and cLogP modulation: optimization of lipophilicity and intracellular exposure to support mitochondrial membrane penetration and maintain cellular activity
Mitophagy Functional Validation and Mechanism Confirmation
Mito-AUTAC activity must be distinguished from nonspecific mitochondrial damage, general cytotoxic stress, or impaired mitochondrial biogenesis. We provide multi-readout validation workflows that integrate mitochondrial localization, membrane-potential analysis, K63-linked ubiquitination, autophagy marker profiling, mitochondrial clearance quantification, and pathway rescue studies.
Mitochondrial uptake and subcellular localization: confirmation of mitochondrial enrichment through MitoTracker co-staining, subcellular imaging, and transmission electron microscopy
Mitochondrial fragmentation and membrane-potential detection: assessment of ΔΨm using JC-1 or TMRE assays, together with ROS profiling
K63-linked ubiquitination and autophagy marker analysis: Western blot analysis of K63-Ub, LC3-II, and p62/SQSTM1 accumulation to confirm autophagy-associated pathway engagement
Mitochondrial mass clearance quantification: flow cytometry, mt-mKeima-based mitophagy analysis, and immunofluorescence quantification of fragmented mitochondrial clearance
Rescue experiments and pathway inhibition: use of autophagy inhibitors such as Bafilomycin A1 and 3-methyladenine (3-MA), or lysosome pathway modulators, to confirm mechanism specificity
Phenotypic Function and Disease-Relevant Model Validation
BOC Sciences supports phenotype-focused Mito-AUTAC validation to determine whether mitochondrial clearance leads to functional improvement, energy recovery, apoptosis reduction, or selective vulnerability in disease-relevant cellular models.
Acute mitochondrial damage rescue experiments: evaluation of Mito-AUTAC effects in CCCP- or Rotenone-induced mitochondrial damage models, including mitochondrial stress recovery and cell-state improvement
ATP recovery and apoptosis inhibition: detection of ATP, cytochrome c release, cleaved caspase-3, and related rescue phenotypes
Disease-relevant cellular model validation: testing in Down syndrome (DS) fibroblasts, neurodegenerative disease induced pluripotent stem cell (iPSC)-derived models, and other mitochondrial dysfunction systems
Anti-tumor mitochondrial vulnerability exploration: assessment of differential mitochondrial stress response and selective killing potential in tumor models with metabolic reprogramming
Developability Assessment and Research Translation Support
Because Mito-AUTAC molecules often contain mitochondria-targeting motifs, degradation tags, and linkers within one structure, their physicochemical properties and mitochondrial selectivity require careful optimization. BOC Sciences supports developability-focused evaluation to improve compound behavior, reduce off-target organelle effects, and generate decision-ready data for further research optimization.
Physicochemical property and permeability optimization: evaluation of solubility, LogP, cellular permeability, and strategies to address low exposure caused by excessive polarity
Off-target effect and mitochondrial selectivity assessment: analysis of mitochondrial DNA content, effects on non-target organelles, and excessive autophagy risk
In vivo PK/PD and distribution research: design of animal research studies to evaluate tissue distribution, mitochondrial targeting efficiency, exposure–response relationships, and pharmacodynamic readouts
Have You Encountered Following Challenges in Mito-AUTAC Development?
Uncertainty about whether a mitochondrial phenotype can be selectively addressed by AUTAC-mediated mitophagy
Difficulty selecting a mitochondrial-targeting ligand that provides sufficient organelle enrichment without excessive stress
Limited understanding of how guanine-derived degradation tag placement affects mitophagy signaling
Weak mitochondrial clearance despite good cellular uptake or mitochondrial localization
Poor separation between productive mitophagy and nonspecific mitochondrial damage
Need to interpret mitochondrial marker loss, autophagy flux, and functional readouts as one coherent dataset
Tell Us Your Challenge
Contact us to discuss how we can help you overcome these hurdles
Our Solutions for Mito-AUTAC Development Challenges
Mito-AUTAC projects require more than simply connecting a mitochondrial ligand and an AUTAC tag. Productive development depends on organelle biology, mitochondrial state, linker geometry, autophagy competence, assay design, and careful interpretation of mitochondrial function data. BOC Sciences provides integrated solutions that connect molecular design with mechanism-driven validation.
Solution for Mitochondrial Targeting Feasibility
A frequent barrier is that researchers may know the mitochondrial phenotype they want to study, but not whether it can be addressed by Mito-AUTAC chemistry. We analyze mitochondrial localization, membrane accessibility, basal mitophagy activity, stress sensitivity, mitochondrial marker suitability, and cell model robustness. This helps clients avoid weak project starts and focus on designs with measurable, mechanism-relevant endpoints.
Solution for Ligand, Tag, and Linker Integration
In Mito-AUTAC design, a strong mitochondrial ligand does not guarantee productive mitophagy. The degradation tag must be positioned so that mitochondrial-associated ubiquitination and autophagy receptor engagement can occur efficiently. We generate focused design matrices covering ligand exit vectors, guanine-tag placement, linker length, polarity, and rigidity, then prioritize structures based on both chemical feasibility and expected biological performance.
Solution for Mitophagy Assay Development
Mitochondrial clearance can be difficult to interpret if only one readout is used. Our solution is to build layered assay systems that combine mitochondrial protein markers such as TOM20, VDAC1, and COX IV with LC3 association, LAMP1 co-localization, autophagy flux markers, and mitochondrial function assays. This multi-readout approach helps distinguish selective mitophagy from mitochondrial toxicity or reduced mitochondrial biogenesis.
Solution for Data Interpretation and Optimization
Mito-AUTAC datasets often include complex relationships among dose, exposure time, mitochondrial stress, autophagy flux, and cell response. We interpret degradation kinetics, Dmax, DC50, mitochondrial function, pathway controls, and compound structure together. This enables clients to decide whether to optimize the targeting ligand, linker, degradation tag, assay window, or cellular model.
Choose BOC Sciences to Build More Reliable Mito-AUTAC Research Programs!
From mitochondrial target assessment and Mito-AUTAC molecular design to custom synthesis, mitophagy assays, ubiquitination analysis, and optimization cycles, BOC Sciences provides tailored support for autophagy-based mitochondrial degradation projects. Our interdisciplinary expertise helps clients reduce design uncertainty, generate decision-ready data, and advance promising Mito-AUTAC candidates with greater confidence.
Our Mito-AUTAC Solutions Support Diverse R&D Organizations
Pharmaceutical Discovery Teams
Discovery teams can use Mito-AUTAC research to explore mitochondrial quality control, stress response, metabolic remodeling, and organelle-selective degradation mechanisms. BOC Sciences supports these programs with rational design, synthesis, cell-based assays, and mechanism-focused data interpretation.
Biotechnology Companies
Biotechnology companies often need proof-of-concept data to determine whether Mito-AUTAC chemistry can support a new mitochondrial biology program. We help accelerate early decision-making through feasibility assessment, focused analog generation, mitochondrial marker profiling, and iterative optimization.
Academic and Translational Research Laboratories
Academic teams may use Mito-AUTAC technology to study mitophagy, mitochondrial dysfunction, oxidative stress, and selective autophagy mechanisms. We provide flexible design, compound synthesis, assay modules, and data support for exploratory and publication-oriented research.
CROs / Technical Service Platforms
CROs and technical platforms may require specialized support for Mito-AUTAC design, chemistry, or mitophagy evaluation. BOC Sciences offers modular cooperation models that complement internal capabilities and strengthen project execution.
End-to-End Mito-AUTAC Technology Development Workflow
01
Inquiry and Requirement Collection
Understand the client's mitochondrial target, cell model, biological question, available ligand information, desired mitophagy readouts, and project-stage objectives.
02
Feasibility and Mito-AUTAC Strategy Assessment
Evaluate mitochondrial localization, organelle accessibility, autophagy competence, assay feasibility, and potential risks to define a practical development route.
03
Proposal Design, Scope Definition, and Quotation
Prepare a tailored research plan covering design scope, analog number, synthesis strategy, assay package, data output, and decision points for optimization.
Design and synthesize Mito-AUTAC molecules by combining mitochondrial-targeting ligands, guanine-derived degradation tags, and optimized linkers.
06
In Vitro and Cell-Based Mitophagy Validation
Evaluate mitochondrial clearance, dose response, time dependence, autophagy pathway engagement, and mitochondrial functional response.
07
Optimization Iteration and Selectivity Assessment
Refine ligand, linker, tag placement, and physicochemical properties based on mitophagy potency, Dmax, ΔΨm, ATP, ROS, and mitochondrial marker data.
08
Molecule Delivery and Data Reporting
Deliver molecular samples, experimental data, structure–activity interpretation, mitophagy profiles, and clear recommendations for the next design cycle.
Advantages
Advantages of Mito-AUTAC Technology
Targets Mitochondrial Quality Control
Mito-AUTAC technology enables researchers to investigate mitochondrial clearance directly, offering a targeted approach to study mitophagy, organelle turnover, and mitochondrial stress response.
Expands Beyond Proteasomal Degradation
Because mitochondria are large organelles rather than soluble proteasome substrates, Mito-AUTAC research expands degradation strategy into autophagy-lysosome biology and organelle-selective clearance.
Supports Mechanistic Mitophagy Studies
Mito-AUTAC designs can be evaluated through K63-linked ubiquitination, autophagy receptor recruitment, LC3 association, lysosomal delivery, and mitochondrial function profiling.
Enables Structure-Guided Optimization
Systematic changes to mitochondrial ligand, linker, and degradation tag architecture allow clients to understand how chemical structure influences organelle localization and mitophagy outcome.
Applications
Applications Supported by Our Mito-AUTAC Technology Platform
Mitochondrial Dysfunction Research
Exploration of selective clearance strategies for damaged or fragmented mitochondria
Evaluation of mitophagy induction in cell models with altered mitochondrial membrane potential
Analysis of TOM20, VDAC1, COX IV, LC3B, LAMP1, and p62/SQSTM1 markers
Functional profiling of ATP production, ROS generation, and mitochondrial network morphology
Neurobiology and Cellular Stress Models
Research support for mitochondrial quality-control mechanisms in neuronal and stress-sensitive cell systems
Investigation of PINK1–Parkin pathway context and autophagy receptor engagement
Comparison of mitochondrial clearance under basal and induced stress conditions
Data interpretation for mitophagy-linked cellular response and recovery phenotypes
Cancer Metabolism and Energy Biology
Design of Mito-AUTAC molecules for studying mitochondria-dependent survival and metabolic adaptation
Evaluation of mitochondrial mass, respiration-related markers, and cellular energy response
Assessment of mitochondrial stress selectivity across different cell models
Data-driven prioritization of organelle, aggregate, or protein degradation strategy
Case Study
Client Success Stories: Mito-AUTAC Technology Development
Project Background
A biotechnology research team wanted to explore whether a mitochondria-targeting AUTAC strategy could promote selective clearance of damaged mitochondria in a stress-sensitive cellular model. The client had a TSPO-oriented ligand scaffold with acceptable cellular activity, but lacked a clear design strategy for attaching a guanine-derived degradation tag without disrupting mitochondrial localization.
Our Support
We first reviewed the ligand structure and identified two derivatization positions that were less likely to interfere with mitochondrial association. Based on these exit vectors, we designed 22 Mito-AUTAC candidates combining guanine-derived degradation tag variants with PEG, alkyl, and semi-rigid linkers ranging from 5 to 14 atoms. After synthesis, we evaluated mitochondrial clearance in a depolarization-stress model using 8 h, 24 h, and 48 h treatment windows. Initial screening showed that highly flexible long linkers increased mitochondrial stress markers without strong lysosomal co-localization. We then prioritized a mid-length semi-rigid linker series and confirmed stronger LC3/LAMP1-associated mitochondrial signal, reduced TOM20 and VDAC1 levels, and improved separation between mitophagy readouts and general cell stress.
Client Testimonial
BOC Sciences helped us convert a broad Mito-AUTAC concept into a structured design and validation workflow. Their ability to connect mitochondrial ligand chemistry, linker selection, and mitophagy assay interpretation gave us a clear optimization direction.
Project Background
A pharmaceutical discovery group had synthesized several early Mito-AUTAC-like compounds but observed inconsistent mitochondrial marker reduction and strong variability across cell models. The client needed help determining whether the molecules were inducing productive mitophagy or simply causing mitochondrial stress.
Our Support
We redesigned the evaluation workflow by pairing compound treatment with mitochondrial marker quantification, LC3B-II monitoring, LAMP1 co-localization imaging, K63-linked ubiquitination analysis, ΔΨm measurement, ATP response, and ROS profiling. The first analysis revealed that two compounds caused rapid ΔΨm loss within 4 h but did not generate robust lysosomal co-localization, suggesting nonspecific mitochondrial disruption. We then designed 16 second-round analogs with lower polarity linkers and altered tag spacing. The optimized analog series produced more gradual mitochondrial marker reduction over 24–48 h, stronger autophagy-receptor-associated signals, and a more interpretable mitophagy profile. The client received a refined structure–mitophagy relationship map and a prioritized molecular template for further research.
Client Testimonial
The BOC Sciences team helped us understand why our first compounds were difficult to interpret. Their multi-readout strategy allowed us to separate mitochondrial stress from genuine mitophagy-linked activity and focus our chemistry resources more effectively.
Why Us
Why Choose BOC Sciences for Your Mito-AUTAC Project?
Integrated Mito-AUTAC Development Support
We provide coordinated support across mitochondrial target assessment, ligand strategy, molecular design, custom synthesis, mitophagy assays, and optimization.
Deep Autophagy-Based Degrader Expertise
Our team understands the unique design logic of AUTAC and mitochondria-focused degradation, including tag placement, linker architecture, and autophagy pathway validation.
Mechanism-Focused Validation
We design studies that connect K63-linked ubiquitination, autophagy receptor engagement, lysosomal delivery, mitochondrial marker reduction, and functional readouts.
Flexible Modular Service Models
Clients can access individual modules, such as linker optimization or mitophagy assay development, or request end-to-end Mito-AUTAC development from concept to optimized analog series.
Data-Driven Design Iteration
We connect chemistry and biology data to refine mitochondrial ligands, AUTAC tags, linker properties, cell models, and assay conditions through rational optimization cycles.
Clear Reporting and Decision Support
We provide organized experimental data, practical interpretation, and clear recommendations to support the next stage of Mito-AUTAC design, screening, or validation.
Mito-AUTAC is a mitochondria-oriented Autophagy-Targeting Chimera technology designed to induce the selective clearance of damaged or abnormal mitochondria through the autophagy-lysosome pathway. Unlike conventional small molecules that mainly modulate protein function, Mito-AUTAC focuses on mitochondrial quality control, mitophagy, and cellular energy homeostasis. It is valuable for studying mitochondrial dysfunction, oxidative stress, neurobiology-related cellular models, and mitochondria-dependent metabolic vulnerability in cancer research.
What is the mechanism of Mito-AUTAC?
The mechanism of Mito-AUTAC generally involves three connected steps. First, the mitochondria-targeting module enriches the molecule at mitochondrial membranes or mitochondrial-associated protein environments. Then, the autophagy-recruiting degradation tag promotes autophagy-recognition signals, such as K63-linked ubiquitination. Finally, the marked mitochondrial fragments or dysfunctional mitochondrial populations are recognized by autophagosomes and delivered to lysosomes for degradation. Mechanism confirmation usually requires multiple readouts, including LC3, LAMP1, p62/SQSTM1, K63-Ub, ATP, and ROS, rather than relying only on mitochondrial marker reduction.
What are the structural features of Mito-AUTAC?
A typical Mito-AUTAC molecule contains three major structural elements: a mitochondria-targeting warhead, an autophagy-recruiting degradation tag, and a linker connecting these two modules. The mitochondria-targeting warhead determines whether the compound can localize efficiently to mitochondria. The degradation tag provides autophagy-recognition or ubiquitination-associated signals. The linker controls spatial distance, flexibility, polarity, membrane penetration, and tag exposure. Therefore, Mito-AUTAC activity depends not only on each individual module, but also on the structural compatibility among the warhead, tag, linker, and cellular context.
What is the difference between Mito-AUTAC and AUTAC?
AUTAC, or Autophagy-Targeting Chimera, is a broader targeted degradation strategy that uses an autophagy-recruiting degradation tag to direct selected cargo toward the autophagy-lysosome pathway. Mito-AUTAC is a mitochondria-focused subtype or application of AUTAC technology. Its design specifically includes a mitochondria-targeting warhead to enrich the molecule at mitochondrial membranes or mitochondrial-associated protein environments, together with an autophagy-recruiting tag and a linker. Therefore, while AUTAC can be applied to different degradation targets depending on the cargo-binding module, Mito-AUTAC is designed to promote selective mitophagy of damaged, dysfunctional, or chemically marked mitochondrial populations.
What are the main challenges in Mito-AUTAC development?
The main challenges in Mito-AUTAC development include selecting an effective mitochondria-targeting ligand, ensuring proper degradation tag exposure, optimizing linker length and polarity, matching the molecule with autophagy-competent cell models, and distinguishing productive mitophagy from nonspecific mitochondrial stress. BOC Sciences can support researchers through systematic optimization of target feasibility, ligand derivatization, tag positioning, linker architecture, cellular model compatibility, and mechanism-focused validation readouts, helping teams establish clearer structure-activity relationships and more practical optimization strategies.
Quick Inquiry
BOC Sciences Support
Please contact us with any specific requirements and we will get back to you as soon as possible.
We invite you to contact us at or through our contact form above for more information about our services and products.
Targets Mitochondrial Quality Control
